REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pt Merck Tbk (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pt Merck Tbk Profile Updated: July 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Merck Tbk is an enterprise based in Indonesia. Its main office is in Jakarta. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 04, 1970. 376 (2024) employees currently work for Pt Merck Tbk. There was a net sales revenue increase of 8.01% reported in Pt Merck Tbk’s latest financial highlights for Q3C2025. Over the same period, its total assets grew by 7.74%. In 2025, Pt Merck Tbk’s net profit margin increased by 2.32%.

Headquarters
Jl Tb Simatupang, No 8, Pasar Rebo
Jakarta; Jakarta; Postal Code: 13760

Contact Details: Purchase the Pt Merck Tbk report to view the information.

Website: http://www.merck.co.id

Basic Information
Total Employees:
Purchase the Pt Merck Tbk report to view the information.
Outstanding Shares:
Purchase the Pt Merck Tbk report to view the information.
Financial Auditors:
Purchase the Pt Merck Tbk report to view the information.
Incorporation Date:
April 04, 1970
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
73.99%
Purchase this report to view the information.
12.66%
Company Performance
Financial values in the chart are available after Pt Merck Tbk report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
8.01%▲
Total Operating Revenue
9.75%▲
Operating Profit
28.03%▲
EBITDA
21.71%▲
Net Profit/Loss for the Period
32.5%▲
Total Assets
7.74%▲
Total Equity
14.21%▲
Operating Profit Margin
2.93%▲
Net Profit Margin
2.32%▲
Return on Equity (ROE)
1.69%▲
Debt / Equity
-710%▼
Quick Ratio
2085.41%▲
Cash Ratio
1.01%▲

Similar companies

PT Emjebe Pharma
 
Pt Kalbe Farma Tbk
PT Otasindo Prima Satwa
 
PT Eagle Indo Pharma
Pt Tempo Scan Pacific Tbk
 
Pt Soho Global Health Tbk
PT Yahi Utama
 
PT Fresenius Kabi Indonesia
PT Imedco Djaja
 
PT Guardian Pharmatama
PT Menarini Indria Laboratories
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo